Nu Skin Appoints New CFO, Hetherington
Ticker: NUS · Form: 8-K · Filed: Mar 18, 2024 · CIK: 1021561
| Field | Detail |
|---|---|
| Company | Nu Skin Enterprises, Inc. (NUS) |
| Form Type | 8-K |
| Filed Date | Mar 18, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-appointment, cfo, compensation
TL;DR
New CFO Jason Hetherington starts March 18th with $500k salary + bonus + $1.5M stock.
AI Summary
Nu Skin Enterprises, Inc. announced on March 15, 2024, the appointment of Jason Hetherington as Chief Financial Officer, effective March 18, 2024. He will receive an annual base salary of $500,000 and a target annual bonus of 75% of his base salary. Additionally, Hetherington will be granted restricted stock units with a target value of $1,500,000, vesting over three years.
Why It Matters
The appointment of a new CFO is a significant leadership change that could signal a shift in financial strategy or operational focus for Nu Skin Enterprises.
Risk Assessment
Risk Level: medium — Changes in key executive positions like CFO can introduce uncertainty regarding future financial strategies and performance.
Key Numbers
- $500,000 — CFO Base Salary (Annual compensation for Jason Hetherington)
- 75% — CFO Bonus Target (Potential performance-based bonus for Jason Hetherington)
- $1,500,000 — CFO Stock Grant (Value of restricted stock units awarded to Jason Hetherington)
Key Players & Entities
- Nu Skin Enterprises, Inc. (company) — Registrant
- Jason Hetherington (person) — Appointed Chief Financial Officer
- $500,000 (dollar_amount) — Annual base salary for new CFO
- 75% (dollar_amount) — Target annual bonus percentage for new CFO
- $1,500,000 (dollar_amount) — Target value of restricted stock units for new CFO
- March 15, 2024 (date) — Date of report
- March 18, 2024 (date) — Effective date of CFO appointment
FAQ
What is Jason Hetherington's previous experience relevant to his new role as CFO?
The filing does not provide details on Jason Hetherington's prior experience.
What are the specific performance metrics tied to the CFO's bonus?
The filing states the bonus is 'target annual bonus' but does not specify the performance metrics.
What is the vesting schedule for the restricted stock units granted to the new CFO?
The restricted stock units are stated to vest over three years.
Was there a search process for the new CFO, and who led it?
The filing does not detail the search process for the new CFO.
What is the expected impact of the new CFO on Nu Skin's financial reporting or strategy?
The filing does not specify the expected impact of the new CFO on financial reporting or strategy.
Filing Stats: 436 words · 2 min read · ~1 pages · Grade level 11.7 · Accepted 2024-03-18 16:18:36
Filing Documents
- ef20024334_8k.htm (8-K) — 26KB
- 0001140361-24-013913.txt ( ) — 156KB
- nus-20240315.xsd (EX-101.SCH) — 4KB
- nus-20240315_lab.xml (EX-101.LAB) — 21KB
- nus-20240315_pre.xml (EX-101.PRE) — 16KB
- ef20024334_8k_htm.xml (XML) — 4KB
02
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On March 15, 2024, Andrew Lipman informed Nu Skin Enterprises, Inc. (the "Company") that he has decided to retire from the Company's Board of Directors (the "Board") and will not stand for re-election to the Board at the Company's 2024 Annual Meeting of Stockholders. The Company and Board extend their gratitude to Mr. Lipman for his contributions and many years of service on the Board. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NU SKIN ENTERPRISES, INC. (Registrant) /s/ James D. Thomas James D. Thomas Chief Financial Officer Date: March 18, 2024